Research ArticleClinical Investigations
Optimal Acquisition Time Window and Simplified Quantification of Dopamine Transporter Availability Using 18F-FE-PE2I in Healthy Controls and Parkinson Disease Patients
Ida Sonni, Patrik Fazio, Martin Schain, Christer Halldin, Per Svenningsson, Lars Farde and Andrea Varrone
Journal of Nuclear Medicine October 2016, 57 (10) 1529-1534; DOI: https://doi.org/10.2967/jnumed.115.171231
Ida Sonni
1Karolinska Institutet, Department of Clinical Neuroscience, Centre for Psychiatry Research, Stockholm, Sweden
2Sapienza University of Rome, Department of Medical-Surgical Sciences and of Translational Medicine, Nuclear Medicine Unit, Rome, Italy
Patrik Fazio
1Karolinska Institutet, Department of Clinical Neuroscience, Centre for Psychiatry Research, Stockholm, Sweden
Martin Schain
1Karolinska Institutet, Department of Clinical Neuroscience, Centre for Psychiatry Research, Stockholm, Sweden
Christer Halldin
1Karolinska Institutet, Department of Clinical Neuroscience, Centre for Psychiatry Research, Stockholm, Sweden
Per Svenningsson
3Karolinska Institutet, Department of Clinical Neuroscience, Centre for Molecular Medicine, Stockholm, Sweden; and
Lars Farde
1Karolinska Institutet, Department of Clinical Neuroscience, Centre for Psychiatry Research, Stockholm, Sweden
4AstraZeneca Translational Science Centre at Karolinska Institutet, PET CoE, Stockholm, Sweden
Andrea Varrone
1Karolinska Institutet, Department of Clinical Neuroscience, Centre for Psychiatry Research, Stockholm, Sweden
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 57, Issue 10
October 1, 2016
Optimal Acquisition Time Window and Simplified Quantification of Dopamine Transporter Availability Using 18F-FE-PE2I in Healthy Controls and Parkinson Disease Patients
Ida Sonni, Patrik Fazio, Martin Schain, Christer Halldin, Per Svenningsson, Lars Farde, Andrea Varrone
Journal of Nuclear Medicine Oct 2016, 57 (10) 1529-1534; DOI: 10.2967/jnumed.115.171231
Optimal Acquisition Time Window and Simplified Quantification of Dopamine Transporter Availability Using 18F-FE-PE2I in Healthy Controls and Parkinson Disease Patients
Ida Sonni, Patrik Fazio, Martin Schain, Christer Halldin, Per Svenningsson, Lars Farde, Andrea Varrone
Journal of Nuclear Medicine Oct 2016, 57 (10) 1529-1534; DOI: 10.2967/jnumed.115.171231